SMAC mimetics overcome apoptotic resistance in ovarian cancer through MSLN-TNF alpha axis
R. Coelho, B. Seashore-Ludlow, S. Schutz…·F. Jacob
This study shows SMAC mimetics overcome apoptotic resistance in ovarian cancer by targeting the MSLN-TNF alpha axis, enhancing cell death and synergizing with chemotherapy.